Inventiva (IVA) Operating Income (2019 - 2021)
Inventiva (IVA) posted quarterly Operating Income of -$16.5 million for Q2 2021, down 68.62% year-over-year from -$52.4 million in Q2 2020, and down 37.21% quarter-over-quarter from -$12.0 million in Q1 2021.
Inventiva (IVA) Operating Income (2019 - 2021) Analysis & Trends
Inventiva's Operating Income history runs 3 years deep, the most recent figure standing at -$16.5 million for Q2 2021.
- In Q2 2021, Operating Income fell 68.62% year-over-year to -$16.5 million; the TTM figure through Jun 2021 stood at -$73.6 million (changed N/A YoY), while the FY2025 annual figure was -$164.1 million, down 57.45% from the prior year.
- Operating Income for Q2 2021 stood at -$16.5 million, down from -$12.0 million in the prior quarter.
- The five-year high for Operating Income was -$7.5 million in Q1 2020, with the low at -$35.4 million in Q4 2020.
- The 3-year median for Operating Income is -$14.2 million (2021), against an average of -$19.1 million.
- The sharpest annual moves came in 2020 and 2021: Operating Income retreated 5.6% in 2020, then sank 68.62% in 2021.
- Inventiva's Operating Income stood at -$33.6 million in 2019, then slipped by 5.6% to -$35.4 million in 2020, then jumped by 53.56% to -$16.5 million in 2021.
- Business Quant data shows IVA's Operating Income at -$16.5 million in Q2 2021, -$12.0 million in Q1 2021, and -$35.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -16.46 Mn |
| Mar 31, 2021 | -11.99 Mn |
| Dec 31, 2020 | -35.43 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.51 Mn |
| Dec 31, 2019 | -33.55 Mn |